XML 51 R39.htm IDEA: XBRL DOCUMENT
v3.25.3

Revenue (Tables) | 9 Months Ended
--- | ---
Sep. 30, 2025
Revenue from Contract with Customer [Abstract] |
Schedule of Disaggregation of Revenue | The table below provides a disaggregation of revenues by type and customer location for the three and nine months ended September 30, 2025 and 2024:
|  | Three Months Ended September 30, |  | Nine Months Ended September 30,
(in thousands) |  | 2025 |  | 2024 |  | 2025 |  | 2024
Types of goods and services |  |  |  |  |  |  |  |
Product revenues, net |  | $ | 15,750 |  |  | $ | 18,016 |  |  | $ | 51,239 |  |  | $ | 52,894 |
License revenues |  | — |  |  | — |  |  | 5,000 |  |  | — |
Royalties |  | 677 |  |  | 448 |  |  | 2,060 |  |  | 1,033 |
Total revenue |  | $ | 16,427 |  |  | $ | 18,464 |  |  | $ | 58,299 |  |  | $ | 53,927 |
Customer Location |  |  |  |  |  |  |  |
U.S. |  | $ | 15,750 |  |  | $ | 18,016 |  |  | $ | 51,239 |  |  | $ | 52,894 |
EMEA(1) |  | 677 |  |  | 448 |  |  | 7,060 |  |  | 1,033 |
Total revenue |  | $ | 16,427 |  |  | $ | 18,464 |  |  | $ | 58,299 |  |  | $ | 53,927 |
(1) Europe, the Middle East and Africa The table below provides a rollforward of the Company’s accruals related to the gross-to-net (“GTN”) sales adjustments for the three and nine months ended September 30, 2025:
(in thousands) |  | Discarded Drug Rebate |  | Other Adjustments |  | Total
Balance as of June 30, 2025 |  | $ | 11,692 |  |  | $ | 2,490 |  |  | $ | 14,182 |
GTN accruals for current period |  | 1,547 |  |  | 3,641 |  |  | 5,188 |
Prior period adjustments |  | (545) |  |  | (235) |  |  | (780) |
Credits, payments and reclassifications |  | — |  |  | (3,810) |  |  | (3,810) |
Balance as of September 30, 2025 |  | $ | 12,694 |  |  | $ | 2,086 |  |  | $ | 14,780 |
Balance as of December 31, 2024 |  | $ | 15,103 |  |  | $ | 2,386 |  |  | $ | 17,489 |
GTN accruals for current period |  | 5,516 |  |  | 11,651 |  |  | 17,167 |
Prior period adjustments |  | (745) |  |  | (808) |  |  | (1,553) |
Credits, payments and reclassifications |  | (7,180) |  |  | (11,143) |  |  | (18,323) |
Balance as of September 30, 2025 |  | $ | 12,694 |  |  | $ | 2,086 |  |  | $ | 14,780 |
The table below provides a rollforward of the Company’s accruals related to the gross-to-net (“GTN”) sales adjustments for the three and nine months ended September 30, 2024:
(in thousands) |  | Discarded Drug Rebate |  | Other Adjustments |  | Total
Balance as of June 30, 2024 |  | $ | 11,251 |  |  | $ | 3,257 |  |  | $ | 14,508 |
GTN accruals for current period |  | 2,051 |  |  | 4,436 |  |  | 6,487 |
Prior period adjustments |  | — |  |  | (378) |  |  | (378) |
Credits, payments and reclassifications |  | — |  |  | (4,224) |  |  | (4,224) |
Balance as of September 30, 2024 |  | $ | 13,302 |  |  | $ | 3,091 |  |  | $ | 16,393 |
Balance as of December 31, 2023 |  | $ | 7,391 |  |  | $ | 3,946 |  |  | $ | 11,337 |
GTN accruals for current period |  | 5,955 |  |  | 12,653 |  |  | 18,608 |
Prior period adjustments |  | (44) |  |  | (1,398) |  |  | (1,442) |
Credits, payments and reclassifications |  | — |  |  | (12,110) |  |  | (12,110) |
Balance as of September 30, 2024 |  | $ | 13,302 |  |  | $ | 3,091 |  |  | $ | 16,393 |
The table below provides the classification of the accruals related to the GTN sales adjustment included in the Company’s unaudited condensed consolidated balance sheets as of September 30, 2025 and December 31, 2024.
(in thousands) |  | September 30, 2025 |  | December 31, 2024
Accounts receivable, net |  | $ | 1,516 |  |  | $ | 1,792 |
Other current and non-current liabilities |  | 13,264 |  |  | 15,697 |
|  | $ | 14,780 |  |  | $ | 17,489 |
Schedule of Product Revenue by Customer | Customers from which we derive more than 10% of our total product revenues for the three and nine months ended September 30, 2025 and 2024 are as follows:
|  | Three Months Ended September 30, |  | Nine Months Ended September 30,
|  | 2025 |  | 2024 |  | 2025 |  | 2024
McKesson |  | 45 | % |  | 39 | % |  | 40 | % |  | 40 | %
AmerisourceBergen Corporation(1) |  | 36 | % |  | 35 | % |  | 39 | % |  | 36 | %
Cardinal Health |  | 19 | % |  | 26 | % |  | 21 | % |  | 24 | %
(1) AmerisourceBergen also operates under the name Cencora.

X
- Definition Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 606 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 5 -Publisher FASB -URI https://asc.fasb.org/1943274/2147479806/606-10-50-5 + Details
Name: | us-gaap_DisaggregationOfRevenueTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_RevenueFromContractWithCustomerAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of entity-wide revenues from external customers for each product or service or each group of similar products or services if the information is not provided as part of the reportable operating segment information. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 40 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482810/280-10-50-40 + Details
Name: | us-gaap_ScheduleOfEntityWideInformationRevenueFromExternalCustomersByProductsAndServicesTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration